Onconetix, Inc. Preferred Stock, Shares Authorized
Onconetix, Inc. (ONCO) had Preferred Stock, Shares Authorized of 10.00 million shares as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2025-08-14
- 2025-06-30: Preferred Stock, Shares Authorized 10.00M shares.
- 2025-03-31: Preferred Stock, Shares Authorized 10.00M shares.
- 2024-12-31: Preferred Stock, Shares Authorized 10.00M shares.
- 2023-09-30: Preferred Stock, Shares Authorized 10.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2025-06-30 | 10.00M shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 10.00M shares 10-Q · filed 2025-06-12 |
| 2024-12-31 | 10.00M shares 10-Q · filed 2025-08-14 |
| 2023-09-30 | 10.00M shares 10-Q · filed 2023-11-17 |
| 2023-06-30 | 10.00M shares 10-Q · filed 2023-10-20 |
| 2023-03-31 | 10.00M shares 10-Q · filed 2023-05-12 |
| 2022-12-31 | 10.00M shares 10-Q · filed 2023-11-17 |
| 2022-09-30 | 10.00M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 10.00M shares 10-Q · filed 2022-08-15 |
| 2022-03-31 | 10.00M shares 10-Q · filed 2022-05-13 |
| 2022-02-23 | 10.00M shares 10-Q · filed 2023-11-17 |
| 2021-12-31 | 10.00M shares 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |